Intas collaborates with IntegriMedical to launch India’s first needle-free injection system for IVF and gynaecology: Our ...

Biohaven’s phase 2 proof-of-concept study with BHV-7000 in major depressive disorder fails to meet its primary endpoint: New Haven, Connecticut Monday, December 29, 2025, 13:00 ...

Our Bureau, Bengaluru Monday, December 29, 2025, 13:45 Hrs [IST] ...

ABL Bio receives USD 40 mn upfront payment for license, research and collaboration agreement for Grabody platform and equity investment from Eli Lilly: Seoul, South Korea Monday, ...

US FDA clears Mabwell’s IND application to initiate phase IIa study of novel anti-ST2 monoclonal antibody, 9MW1911 to treat moderate-to-severe COPD: Shanghai Monday, December 29 ...

Edgewise announces completion of EDG-7500 CIRRUS-HCM phase 2 parts B & C and favourable interim safety results from the ongoing part D study in hypertrophic cardiomyopathy ...

Corona Remedies announces commencement of capacity expansion for commercial production at Bhayla facility: Our Bureau, Mumbai Monday, December 29, 2025, 13:30 Hrs [IST] Corona Rem ...

Akums Drugs & Pharmaceuticals inks MoU with Sharda University to boost industry–academia collaboration: Our Bureau, Bengaluru Monday, December 29, 2025, 16:15 Hrs [IST] Akums Dr ...

Italfarmaco & JCR Pharma enter commercialisation agreement for givinostat to treat Duchenne muscular dystrophy in Japan: Milan, Italy Monday, December 29, 2025, 14:00 Hrs [IST] It ...

Mumbai-based NMIMS Shobhaben Pratapbhai Patel School of Pharmacy gets 3 awards at 74th IPC: Our Bureau, Chennai Monday, December 29, 2025, 12:40 Hrs [IST] At the recent 74th India ...

IPC to host 36th Skill Development Programme on Pharmacovigilance from 9 to 13 March 2026: Shardul Nautiyal, Mumbai Monday, December 29, 2025, 09:00 Hrs [IST] The Indian Pharmacop ...

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...